Recent Analyst Forecasts and Stock Ratings
Alnylam Pharmaceuticals, Inc. FAQ's
Alnylam Pharmaceuticals, Inc. has been rated by research analysts at BMO Capital, Scotiabank, Bernstein, Canaccord Genuity, Bank of America Securities, RBC Capital in the past 90 days.